Latest News

At ASCRS 2017, ZEISS showcases SMILE laser vision correction and SWEPT Source Biometry with the Barrett Suite

Additionally for ophthalmic diagnostics, ZEISS presents its extensive diagnostic portfolio integrated with ZEISS FORUM for efficient chronic disease management. For CIRRUS OCT, ZEISS introduces AngioPlex with AngioPlex Metrix** helping doctors to objectively assess changes in retinal vasculature.

Open Innovation of ZEISS and the Advanced Retina Imaging Network advances Swept-Source OCT technology for better vision care

At ARVO 2017, ZEISS demonstrates new Swept-Source OCT and OCT Angiography technology, which was developed through its Open Innovation approach, to support researchers in their quest for new clinical applications for diseases affecting the retina.

The All-new Robotic Visualization System KINEVO 900 from ZEISS Revolutionizes Neurosurgical Visualization

The three-in-one solution sets a new benchmark in assisting surgeons with additional insights for better clinical decisions, while reducing complexity and manual repositioning

ZEISS integrates new Barrett Suite of highly accurate IOL formulas into IOLMaster SWEPT Source Biometry

The Barrett Suite, three new highly accurate IOL power calculation formulas, with the SWEPT Source OCT technology of the IOLMaster 700 from ZEISS, can help cataract surgeons conveniently achieve target refraction and reduce the risk of refractive surprises for improved refractive outcomes for their patients.

First SMILE Laser Eye Surgery Procedures for U.S. Navy Performed at Naval Medical Center San Diego

Cmdr. John B. Cason, M.D., who will lead an upcoming Tri-Service study on the benefits of SMILE laser vision correction for patients working in extreme environments and dynamic roles unique to service members and first responders, performed the first minimally-invasive SMILE treatments for the U.S. Navy on Thursday April 6, 2017 at the Navy Refractive Surgery Center San Diego.

First SMILE Laser Eye Surgery Procedure Performed on U.S. Service Members Expands Vision Correction Options for Myopia in the Department of Defense

ZEISS ReLEx SMILE provides a new laser vision correction option for U.S. service members who serve in physically demanding and dynamic roles where excellent visual acuity is critical. Dr. Bruce Rivers performed the first SMILE minimally-invasive laser eye surgery procedure for the U.S. Department of Defense at Fort Belvoir Community Hospital in Virginia on Thursday March 16, 2017.

First SMILE Vision Correction Procedure for Myopia Performed in the U.S.

Carl Zeiss Meditec announces the first ReLEx® SMILE minimally-invasive laser eye surgery procedure has been performed in the United States with the ZEISS VisuMax femtosecond laser by Dr. Jon G. Dishler at the Dishler Laser Institute in Greenwood Village, Colorado.

ZEISS receives the first US FDA Clearance for Swept-Source OCT posterior ocular imaging with PLEX Elite 9000

ZEISS continues to set the pace in OCT innovation with Swept-Source OCT imaging that expands the potential for clinical researchers to open new frontiers of discovery in diseases affecting the retina. ZEISS PLEX Elite 9000 allows the potential to see deeper, wider and in more detail from vitreous to sclera than previously possible with other technologies.

Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer

The Medical Technology Business Group of ZEISS continues to strengthen its leadership team with the appointment of distinguished refractive surgeon and clinical professor of ophthalmology, Steven C. Schallhorn, MD as Chief Medical

Carl Zeiss Meditec appoints Andrew Ihan Chang to lead Global Sales for Ophthalmic Devices

The Medical Technology Business Group of ZEISS has appointed Andrew Ihan Chang to lead its worldwide sales organization for the newly consolidated Strategic Business Unit Global Ophthalmic Devices.

ZEISS receives US FDA Approval for VisuMax SMILE vision correction procedure, the latest advancement in laser eye surgery

The Medical Technology Business Group of ZEISS announces the introduction in the US of the VisuMax® Small Incision Lenticule Extraction (SMILE) procedure, the latest advancement in refractive surgery for the correction of myopia.

Carl Zeiss Meditec Recruits James V. Mazzo to Lead its Newly Consolidated Ophthalmology Organization

Carl Zeiss Meditec AG consolidates its ophthalmology activities in a single Strategic Business Unit; James V. Mazzo will head the new ophthalmology division.

Recent studies have shown new cataract technologies from ZEISS achieve excellent refractive outcomes and a reduced risk of refractive surprises

ZEISS Cataract Suite markerless has shown in recent clinical studies to support surgeons in achieving excellent refractive outcomes with post-operative refractive cylinder within +/- 0.50D (diopters) for up to 99% of patients.

ZEISS receives CE Mark approval for PLEX Elite 9000 Swept-Source OCT

New Swept-Source OCT technology platform from ZEISS empowers leading clinical experts around the world to expand discovery in clinical research for retina.

New high resolution Fundus Cameras VISUCAM 224 / 524 for more confident diagnosis

ZEISS introduces a new generation of high resolution Fundus cameras at the American Academy of Ophthalmology (AAO) in Las Vegas.

ZEISS presents innovations that support ophthalmologists in their work

At the 2015 Annual Meeting of the American Academy of Ophthalmology (AAO) in Las Vegas, ZEISS announces innovations for clinical excellence and practice performance in ophthalmology.

ZEISS Sets the Pace in OCT Innovation with First FDA 510(k) Clearance of OCT Angiography Technology

AngioPlex OCT Angiography from ZEISS is the next generation of vascular imaging, providing non-invasive 3D images of blood flow in the eye to help eye care professionals detect retinal diseases earlier and improve treatment and management of these diseases

ZEISS Presents Its New Generation of Vascular Imaging: OCT Angiography

Prolific research from ZEISS Medical Technology at the recent 2015 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Denver highlights the company’s standing as the leader in OCT technology and innovation

Meeting the Needs of Ophthalmologists: ZEISS Showcases Integrated Solutions that Deliver Faster Practice and Surgical Workflow and Address Critical Diagnostic Challenges

At the 2015 American Society of Cataract and Refractive Surgery (ASCRS) Annual Symposium in San Diego, ZEISS Medical Technology highlights its new Humphrey® Field Analyzer 3 as part of the Glaucoma Suite, a connected solution for accurate diagnosis and confident disease management. The company also presents integrated systems that improve and streamline ophthalmic surgery with the ZEISS Cataract Suite markerless and the RESCAN™700 intraoperative OCT.

The New Humphrey Field Analyzer 3 from ZEISS Sets a New Standard for Efficient Visual Field Testing

New HFA3 offers gold-standard perimetry performance with technological advances – such as automated trial lens correction – that are designed to save time and reduce errors, plus test results equal to and interchangeable with test results from previous Humphrey perimeters.

Carl Zeiss Meditec invests in innovative radiotherapy solution for wet age-related macular degeneration developed by Oraya Therapeutics, Inc.

Oraya Therapy represents an attractive new treatment option for patients

New ZEISS Integrated Intraoperative OCT Provides Surgeons Unprecedented Views of Transparent Ocular Structures in a Surgical Microscope

The medical technology company ZEISS was the first to introduce a surgical microscope and the first to commercially offer OCT for ophthalmic applications. By merging two gold standards into one system, ZEISS has created another first: a surgical microscope with integrated intraoperative OCT, the OPMI LUMERA® 700 and RESCAN™ 700. Now available in the Unites States, RESCAN 700 provides ophthalmic surgeons the highest-quality intraoperative OCT visualization of the eye without any interruption of surgery.

ZEISS Expands Gold-Standard Cataract, Glaucoma and Retina Offerings at AAO 2014 that Enhance Clinical Decisions and Improve Practice Efficiency

Innovations from ZEISS in key diagnostic and surgical areas at the 2014 American Academy of Ophthalmology (AAO) meeting in Chicago, including a comprehensive line of basic diagnostics / Additional distribution channel for cataract surgery products

Essential Line from ZEISS offers its customers an expanded diagnostic portfolio

New ZEISS Cataract Suite Markerless Makes Surgical Workflow More Efficient with Precise Toric IOL Alignment

Suite combines gold-standard biometry and visualization products with new technology – recently cleared by the FDA – that eliminates the need to mark the cornea for optimal IOL placement

Quality and efficiency right from the start: with the Essential Line, ZEISS offers its customers an expanded diagnostic portfolio

Focused on Integrated Customer-oriented Solutions: ZEISS Impresses More and More Doctors with its Ophthalmic Surgery Offerings

Truly integrated and clinically proven systems from ZEISS in focus at the 2014 ASCRS in Boston.

ZEISS broadens portfolio of Intraocular Lenses

Acquisition of US-based manufacturer of Intraocular Lenses (IOLs) Aaren Scientific further expands comprehensie offering in surgical ophthalmoloy

New Glaucoma Diagnostic and Management Application from ZEISS supports Efficient Clinical Assessment at the Point of Care

FORUM Glaucoma Workplace from ZEISS brings together exam data and analysis in new clinically relevant ways to aid in the diagnosis and management of glaucoma

New breast cancer study results published in The Lancet compare targeted radiotherapy during surgery with ZEISS INTRABEAM to traditional post-surgical radiotherapy treatment

5-year results of international TARGIT-A clinical trial support targeted intraoperative radiotherapy (TARGIT) delivered with the ZEISS INTRABEAM as non-inferior to external beam radiotherapy (EBRT) for selected early stage breast cancer patients.

New Diagnostic and Surgical Innovations and Data Management Solutions from ZEISS presented at 2013 Annual Meeting of American Academy of Ophthalmology (AAO)

Innovations from ZEISS for glaucoma, cataract surgery, eye care data management, laser vision correction and basic diagnostics at the AAO 2013 in New Orleans

ZEISS Expands Its Offering for Cancer Treatment: Targeted Radiotherapy Now also Available for Skin and Gastrointestinal Tumors

Expanded applications of ZEISS INTRABEAM receive approval in USA, Europe and China

ZEISS and Henry Schein enter into US distribution partnership for premium line of ZEISS dental microscopes and loupes

Agreement between ZEISS and leading distributor Henry Schein allows US dentists to easily incorporate into their practice premium dental microscopes and loupes for improved patient care

ZEISS Cataract Suite featuring CALLISTO eye Introduced at Annual Cataract and Refractive Surgery Congress in San Francisco

Two ZEISS gold standard technologies combine with the innovative CALLISTO eye OR management system providing greater efficiency and enhanced surgical precision.

FORUM Viewer App Makes Diagnostic Patient Data Available for Mobile Use

Intuitive and convenient use on the iPad

Carl Zeiss Recognized for a Decade of Exceptional Customer Care

ZEISS receives the 2012 NorthFace ScoreBoard Award for exceeding customer expectations

New Family of OCT Products and New Eye Care Data Management Software Introduced at Annual Meeting of Ophthalmology

Carl Zeiss Meditec at the 2012 AAO-APAO Joint Meeting in Chicago

ZEISS introduces new family of OCT products

Modernized new OCT platforms span full spectrum of multi-modality imaging for glaucoma and retinal disease